Pinion Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Pinion Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Sell	475 -77	-14%	-$35.9K	0.05%	169
2025 Q4	$250K	Sell	552 -78	-12%	-$33.6K	0.06%	151
2025 Q3	$265K	Sell	630 -42	-6%	-$17.6K	0.07%	145
2025 Q2	$299K	Sell	672 -1	-0.1%	-$461	0.1%	133
2025 Q1	$326K	Buy	673 +46	+7%	+$21.4K	0.07%	117
2024 Q4	$252K	Sell	627 -208	-25%	-$96.4K	0.1%	135
2024 Q3	$388K	Buy	835 +253	+43%	+$122K	0.16%	113
2024 Q2	$273K	Buy	+582	New	+$253K	0.14%	125

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pinion Investment Advisors's VRTX Position: Q1 2026 in Review

Pinion Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, selling an estimated $35.9K and leaving 475 shares worth $212K. The position accounts for 0.05% of the portfolio, ranked #169.

Pinion Investment Advisors first reported a position in VRTX in Q2 2024 and has held it in 8 quarters since. The position peaked at $388K in Q3 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Pinion Investment Advisors held 475 shares of Vertex Pharmaceuticals worth $212K as of Q1 2026.
Pinion Investment Advisors sold 77 Vertex Pharmaceuticals shares in Q1 2026, an estimated $35.9K.
Vertex Pharmaceuticals made up 0.05% of Pinion Investment Advisors's portfolio in Q1 2026, its #169 holding.
Pinion Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Pinion Investment Advisors's Vertex Pharmaceuticals position peaked at $388K in Q3 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Pinion Investment Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.